Peforelin

Peforelin (INN), or peforelin acetate, sold under the brand name Maprelin, is a gonadotropin-releasing hormone agonist (GnRH agonist) medication which is used in veterinary medicine in Europe and Canada.[1][2][3][4] It is a GnRH analogue and a synthetic peptide, specifically a decapeptide.[1][3][4] The drug was introduced for veterinary use by 2001.[5]

Peforelin
Clinical data
Trade namesMaprelin
Other namesLamprey GnRH-III; H-Pyr-His-Trp-Ser-His-Asp-Trp-Lys-Pro-Gly-NH2; XHWSHDWKPG
Routes of
administration
Injection
Drug classGnRH agonist
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
ECHA InfoCard100.223.356
Chemical and physical data
FormulaC59H74N18O14
Molar mass1259.353 g·mol−1
3D model (JSmol)

See also

References

  1. https://www.drugs.com/international/peforelin.html
  2. https://www.drugs.com/vet/maprelin-xp-10-can.html
  3. Löscher W, Richter A, Potschka H (3 September 2014). Pharmakotherapie bei Haus- und Nutztieren: Begründet von W. Löscher, F.R. Ungemach und R. Kroker. Enke. pp. 435–. ISBN 978-3-8304-1251-9.
  4. Rodriguez-Martinez H (1 April 2010). Control of Pig Reproduction VIII. Nottingham University Press. pp. 190–. ISBN 978-1-907284-53-3.
  5. http://www.sgau.ru/files/pages/846/14713368000.pdf#page=48



This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.